Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HAT Technology & Innovation Fund is a private equity fund managed by HAT SGR, a leading independent Italian asset management company. The fund specializes in growth capital investments, primarily targeting small and medium-sized enterprises (SMEs) that demonstrate high innovation and technological potential. Its investment strategy focuses on sectors such as digital transformation, software, and advanced manufacturing, with selective exposure to healthcare technology and medtech. By providing capital and strategic support, the fund assists its portfolio companies in scaling operations and expanding into international markets. HAT SGR is recognized as one of the most active private equity players in the Italian market for technology-driven growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HAT Technology & Innovation Fund.